Slipczuk, Leandro

BDNF activates mTOR to regulate GluR1 expression required for memory formation

Slipczuk, L., Bekinschtein, P., Katche, C., Cammarota, M., Izquierdo, I., & Medina, J. H. (2009) · PLoS ONE

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 246

New approaches to triglyceride reduction: is there any hope left?

Filtz, A., Parihar, S., Greenberg, G. S., Park, C. M., Scotti, A., Lorenzatti, D., Badimon, J. J., Soffer, D. E., Toth, P. P., Lavie, C. J., et al. (2024) · American Journal of Preventive Cardiology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 26

The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials

Sayed, A., Shazly, O., Slipczuk, L., Krittanawong, C., Baloch, F., & Virani, S. S. (2024) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 19

Racial and regional differences in efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: a systematic review and meta-analysis

Kani, R., Miyamoto, Y., Saito, T., Watanabe, A., Matsubara, K., Ejiri, K., Iwagami, M., Slipczuk, L., Hosseini, K., Fujisaki, T., et al. (2025) · International Journal of Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 10

Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?

Abdul Jabbar, A. B., Inam, M., Butt, N., Khan, S. S., Sheikh, S., Khoja, A., Perry, B., Gomez, G. Z., Slipczuk, L., & Virani, S. S. (2025) · Current Atherosclerosis Reports

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 7

Characterization of Aortic Valve Stenosis by CT Angiography in a Diverse US Cohort

Lorenzatti, D., Filtz, A., Pina, P., Geers, J., Gilman, J., Daich, J., Ippolito, P., Aftab, A., Schenone, A. L., Gongora, C. A., et al. (2025) · Circulation: Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 7

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies

Alam, U., Mathai, S. V., Filtz, A., Kuno, T., Badimon, J. J., Sniderman, A. D., Virani, S. S., Toth, P. P., Shapiro, M. D., Lavie, C. J., et al. (2026) · Current Cardiology Reports

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 4

APOC3 inhibition: The strongest case yet for triglyceride targeting

Shapiro, M. D., & Slipczuk, L. (2025) · Progress in Cardiovascular Diseases

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 2